- In March 2024, DSM-Firmenich partnered with SCN BestCo to launch a new line of omega-3 gummies, which feature EPA and DHA ingredients. This collaboration aims to offer a convenient and consumer-friendly way to incorporate omega-3 fatty acids into daily diets for improved health benefits
- In March 2024, Epax, a subsidiary of the Norwegian company Pelagia AS, invested USD 40 million in a cutting-edge distillation facility to implement advanced distillation technology for producing ultra-concentrated omega-3
- In February 2024, Epax launched a full-spectrum oil that combines omega-3, omega-9, and omega-11, with a focus on skin health supplements. The new EPAX Omega 3-9-11 is rich in Omega-3 EPA and DHA, which are known for their heart and brain health benefits
- In December 2021, GC Rieber VivoMega, a producer of omega-3 concentrates, announced plans to further expand its facilities to increase the production capacity of its VivoMega omega-3 in the coming years. The company had previously completed plant expansions in 2013 and 2016 to meet growing market demands
- In October 2021, GC Rieber VivoMega launched the VivoMega softgel sampling program in North America, aimed at showcasing the health benefits of its omega-3 concentrates. The program was designed to reduce sensory issues such as the fishy aftertaste or belches commonly associated with omega-3 oils
